JEFFREY WALSH: Open Payments
NPI 1962070102 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,914 in 147 payments from 28 companies in 2025. Trend: 2023 $1,654 · 2024 $3,854 · 2025 $8,914
Food & beverage: $3,382Travel & lodging: $2,817Speaker / faculty: $2,376Education: $189Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 15 | $3,890 |
| Inspire Medical Systems, Inc. | 37 | $3,106 |
| AstraZeneca Pharmaceuticals LP | 12 | $472 |
| GlaxoSmithKline, LLC. | 13 | $189 |
| Avadel CNS Pharmaceuticals, LLC | 16 | $171 |
| Viatris Specialty LLC | 11 | $161 |
| Grifols USA, LLC | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Vifor Pharma, Inc. | 3 | $69 |
Products named: XYWAV, INSPIRE, AIRSUPRA, LUMRYZ, DUPIXENT, YUPELRI, NUCALA, Prolastin-C Liquid.
Industry payments across UT — which companies pay providers there.
